KERNX Health review

Take a quarter dose here and you almost certainly pay what a full dose costs. KERNX never says that in a sentence — which is itself worth knowing — but it publishes one monthly figure per molecule and folds dose changes into the membership, so nothing about your dose moves the bill. Give it credit for two unusual things. It publishes both the discounted founding rate and the standard rate that discount is measured against, where most sites publish only the cheap number. And it rules out prepayment outright: "There is no long term contract and no multi month prepayment", so you are never nudged into a year-long lock-in. It also names its pharmacy and its regulatory class. Two things will cost you. A per-visit consultation fee sits outside the monthly price and recurs by visit type rather than once. And the founding rate has no published end date, so the standard rate works as an anchor rather than a deadline.

Vs median

$40/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Billed separately

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

KERNX Health dispenses through a Empower Pharmacy facility. No bloodwork is required before you start. A clinician review is billed separately.

KERNX Health sells compounded semaglutide and compounded tirzepatide as a flat monthly membership billed through Stripe, with medication, shipping and ongoing support inside the rate and dose changes treated as part of the membership rather than a repricing event. It names its pharmacy — Empower Pharmacy, "an FDA registered 503B outsourcing facility" — and says the dispensing pharmacy is identified in the patient's treatment and fulfillment information. It publishes both a discounted founding rate and the standard rate that applies once founding membership closes, and rules out prepayment outright. A per-visit consultation fee is charged separately from the plan. KERNX Health LLC is registered in Washington, DC, with a HIPAA notice effective April 2026.

One monthly figure per molecule with dose changes folded into the membership, so a patient holding at a quarter dose pays what a full-dose patient pays. KERNX never states this in a sentence, which makes it harder to check than at providers that say it outright

• A per-visit consultation fee sits outside the monthly price — $25 to $60 by visit type — charged with the treatment charge, so the real first-month cost is $154–$189 on semaglutide or $224–$259 on tirzepatide
• The homepage says "You pay a flat monthly rate with no claims to file" and the FAQ "Are there hidden fees?" answers "Your monthly plan price covers medication, shipping, and ongoing support" — then discloses the consultation fee in the very next sentence
• "Founding member pricing" has no published end date, so the $249/$299 standard block functions as an anchor against a discount that never visibly expires
• No state list is published — only "nationwide through its licensed physician network"
• A young operation: KERNX Health LLC, Washington, DC, with a HIPAA notice effective April 2026
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

KERNX Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan